Velarion · Company Intelligence
CompBrief
Fiscal year 2025

Thane Wettig — FY2025 total compensation $2,113,842

Thane Wettig is Chief Executive Officer and Director of Kyntra Bio, Inc. (FGEN). The company reported total compensation of $2,113,842 for fiscal year 2025.

01

Fiscal year 2025 compensation

Salary$665,000
Bonus$0
Stock awards$0
Option awards$846,023
Non-equity incentive plan$580,545
Pension and non-qualified deferred compensation$0
All other compensation$22,274
Total$2,113,842

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.

Cited to the compensation disclosure Kyntra Bio, Inc. filed April 27, 2026, accession 0001193125-26-182044.

02

History — every fiscal year held

Fiscal yearRoleSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
FY2025Chief Executive Officer and Director$665,000$0$0$846,023$580,545$0$22,274$2,113,842
FY2024Chief Executive Officer and Director$665,000$0$284,690$1,231,568$434,611$0$26,244$2,642,113

Totals as disclosed in each year's own compensation disclosure for Kyntra Bio, Inc..

03

Peer context

Peer-group chief executive median$2,655,774
Difference from that median$-541,932
Percentile within the disclosed peer group20th
Peers with a disclosed figure3

Medians and percentiles are computed across the peer group Kyntra Bio, Inc. discloses in its own compensation disclosure.

04

The other named executive officers of Kyntra Bio, Inc.

Named executive officerRoleFY2025 total
Thane Wettig this pageChief Executive Officer and Director$2,113,842
Christine Chungformer Senior Vice President, China Operations$1,181,108
David DeLuciaChief Financial Officer$1,110,999

The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Kyntra Bio, Inc. compensation brief.

05

The company page

Thane Wettig's compensation sits inside Kyntra Bio, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.

The Kyntra Bio, Inc. (FGEN) compensation brief